Exclusive: Ozempic Prescription Startup Shake-Up Hits Management
A significant leadership reshuffle at a high-profile exclusive: ozempic prescription startup signals a broader pivot ...
New investors in 2023 must understand the current market landscape. Familiarize yourself with essential tips and strategies to thrive in investing.
28,353 articlesA significant leadership reshuffle at a high-profile exclusive: ozempic prescription startup signals a broader pivot ...
From the brink to AI dominance, AMD’s decade-long rebound reshapes how investors view chipmakers. Here’s what the num...
Micron Technology posted blowout Q3 2026 results, sending shares higher and lifting SanDisk and Western Digital as in...
As Tesla prepares for its July 22 report, investors are focused on margin expansion, software and services momentum, ...
ConocoPhillips announces a strategic pivot from growth to cash harvesting as it completes the Marathon Oil deal and b...
DraftKings reports a mixed Q1 2026 while signaling growth hinges on prediction markets and regulatory clarity. A path...
BitMine plans a $300 million perpetual preferred stock sale to acquire ETH, expand staking infrastructure, and invest...
As AI builds out more data centers, the U.S. power grid faces mounting strain. HPE’s warning of a looming 19 gigawatt...
Point closes $508.6m securitization, the largest HEI-backed deal to date, as institutional buyers pile into home equi...
Strive raises the dividend on SATA preferred stock to 12.75% and deploys $50 million into Strategy's STRC, while incr...
Oklo faces a pivotal Q1 2026 earnings night as it pivots from regulatory progress to early commercial milestones. Wat...
Investors are weighing SpaceX IPO buzz against a broader rotation into blue chips, with traders signaling a shift awa...